Hemogenyx Gets US Patent For Postnatal Hemogenic Endothelial Cells Read More
Hemogenyx Raises GBP648,200 To Continue T Cell Therapy Development Read More
Hemogenyx Shares Jump On Promising Data From Blood Cancer Therapy Read More
Hemogenyx CDX Antibody Treatment Potentially "Life-Saving" Read More
Hemogenyx Inks USD75,000 Research Deal With Undisclosed Global Firm Read More
Hemogenyx Interim Loss Widens But CDX Antibody Work Progresses Read More
LONDON (Alliance News) - Biotechnology company Hemogenyx Pharmaceuticals PLC said on Tuesday it has appointed Marc Feldmann as executive chairman, with effect next will be who Read More
